Announced Tue, 30 Dec · 13:33 IST

Arvee Laboratories (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

ARVEE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Arvee Laboratories has informed the NSE that its trading window will be closed from 1st January 2026 until 2 working days after the declaration of financial results for the quarter ended 31st December 2025. This closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015. Promoters, Directors, Key Managerial Personnel, Designated Persons, and their immediate relatives are prohibited from trading in the company's securities during this period. The letter is signed by Managing Director Shalin Patel and dated 30th December 2025.

Likely market impact

This is a routine regulatory compliance filing and does not impact shareholders directly. It signals that the company is likely to announce its Q3 FY26 results soon, which is the standard reason for such trading window closures.